乳腺癌放疗发生放射性肺炎相关影响因素的研究进展  

Research progress on influencing factors of radiation pneumonitis after radiotherapy for breast cancer

作　　者：刘静 周东 贺加贝 王若雨[1] LIU Jing;ZHOU Dong;HE Jiabei;WANG Ruoyu(Department of Medical Oncology,Affiliated Zhongshan Hospital of Dalian University,Dalian 116001,China)

机构地区：[1]大连大学附属中山医院肿瘤四科,辽宁大连116001

出　　处：《大连医科大学学报》2022年第5期440-445,共6页Journal of Dalian Medical University

摘　　要：放射性肺炎(radiation pneumonitis,RP)是乳腺癌患者放疗比较常见的不良反应,会影响患者的治疗效果和生存质量。目前,尚无明确的指标可以预测RP在乳腺癌放疗患者中的发生。本文主要从乳腺癌放疗合并其他治疗方式、放射剂量学因素以及临床因素等方面综述RP的相关影响因素,为临床上预防和治疗RP提供参考。Radiation pneumonitis(RP)is a common adverse reaction of breast cancer patients undergoing radiotherapy,which affects the therapeutic effect and quality of life of patients.So far,there are no clear indicators to predict the occurrence of RP in patients with breast cancer undergoing radiotherapy.In this paper,the relevant influencing factors of RP are reviewed from the aspects of combined treatment of breast cancer radiotherapy,radiological factors and clinical factors,so as to provide reference for the clinical discovery,prevention and treatment of RP.

关 键 词：乳腺癌 放射性肺炎 影响因素 

分 类 号：R739.9[医药卫生—肿瘤]